Fig. 3: Outcome from HSCT according to MDS subtype and karyotype. | Bone Marrow Transplantation

Fig. 3: Outcome from HSCT according to MDS subtype and karyotype.

From: Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Fig. 3

A Disease-free survival according to most advanced MDS type prior to transplantation, B Disease-free survival, and C cumulative incidence of relapse according to most advanced MDS type stratified by karyotype. RCC refractory cytopenia of childhood, MDS-EB MDS with excess blasts, MDS-EBt MDS with excess blasts in transformation, AML MDS-related acute myeloid leukemia, N numbers in subgroup, E events.

Back to article page